Throughout the last three months, 5 analysts have evaluated Azenta (NASDAQ:AZTA), offering a diverse set of opinions from bullish to bearish. The following table provides a quick overview of their ...

Life sciences company Azenta (NASDAQ:AZTA) will be reporting results this Tuesday before the bell. Here’s what to look for. Azenta beat analysts’ revenue expectations by 2% last quarter, reporting ...

Life sciences company Azenta (NASDAQ:AZTA) reported Q3 CY2025 results topping the market’s revenue expectations , with sales up 5.5% year on year to $159.2 million. Its non-GAAP profit of $0.19 per ...

Azenta reported Q2 2025 revenue of $143 million, representing 5% year-over-year growth on a reported basis and 6% on an organic basis. The company achieved a non-GAAP EPS of $0.05 and an adjusted ...

Azenta (NASDAQ:AZTA) is preparing to release its quarterly earnings on Tuesday, 2024-11-12. Here's a brief overview of what investors should keep in mind before the announcement. Analysts expect ...

Azenta, Inc. ((AZTA)) has held its Q4 earnings call. Read on for the main highlights of the call. Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with ...

Azenta (NASDAQ:AZTA) will release its quarterly earnings report on Friday, 2025-11-21. Here's a brief overview for investors ahead of the announcement. Analysts anticipate Azenta to report an earnings ...

Azenta has also announced plans to sell B Medical (TASE: PMCN) Systems, a move expected to be well-received by the investment community. This strategic shift is reflected in the company's fiscal year ...

During the last three months, 7 analysts shared their evaluations of Azenta (NASDAQ:AZTA), revealing diverse outlooks from bullish to bearish. The table below provides a snapshot of their recent ...